Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
6 drugs in development
By Therapeutic Area
top 4
R&D Momentum
67/100
Pipeline Velocity
43/100
Trial Completion Rate
93/100
Pipeline Concentration
28/100
Pipeline Freshness
57/100
Strategic Signals
Activity
Last 14 days
Effect of Analgesia With Acetaminophen-Mannitol Injection on Postoperative Delirium in Older Patients Undergoing Non-cardiac Surgery: Protocol for an Open-label Randomized Controlled Trial
Effect of Different Bed Head Angles on Intraoperative Hypoxemia in Patients Undergoing Painless Gastroenteroscopy: A Prospective Randomized Controlled Study
RET-Targeted Molecular Imaging Probes in Prostate Cancer
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)